Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.951 EUR | -1.25% | +2.37% | -12.59% |
Apr. 30 | Sweden’s Competition Watchdog Prohibits Oriola's Dose Dispensing Unit Sale | MT |
Apr. 29 | ApotekstjÄNst Sverige Ab cancelled the acquisition of Svensk Dos AB. | CI |
Sales 2024 * | 1.55B 1.68B | Sales 2025 * | 1.59B 1.72B | Capitalization | 180M 195M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 16M 17.26M | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | 5.3M 5.72M | Net cash position 2025 * | 23.36M 25.19M | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
10.7
x | Employees | 800 |
Yield 2024 * |
8.31% | Yield 2025 * |
9% | Free-Float | 70.11% |
Latest transcript on Oriola Oyj
1 day | +1.16% | ||
1 week | +4.67% | ||
Current month | +7.60% | ||
1 month | -9.66% | ||
3 months | -6.14% | ||
6 months | +1.26% | ||
Current year | -11.49% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 11-12-31 | |
Director of Finance/CFO | 54 | 22-11-30 | |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 22-12-31 | |
Director/Board Member | 55 | 22-12-31 | |
Harri Pärssinen
BRD | Director/Board Member | 61 | 19-01-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +3.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 0.951 | -1.25% | 149 777 |
24-05-13 | 0.963 | +1.16% | 109,810 |
24-05-10 | 0.952 | +1.38% | 143,180 |
24-05-08 | 0.939 | +1.08% | 294,829 |
24-05-07 | 0.929 | +0.98% | 96,791 |
Delayed Quote Nasdaq Helsinki, May 13, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.49% | 195M | |
+19.79% | 72.09B | |
-2.74% | 23.88B | |
+11.74% | 8.89B | |
+9.15% | 8.46B | |
-17.39% | 8.29B | |
+7.33% | 4.9B | |
+17.69% | 4.34B | |
-3.66% | 3.98B | |
-2.54% | 3.89B |
- Stock Market
- Equities
- OKDBV Stock